Live from the NIH registry
Studies recruiting near Lake Charles right now
Top 25 of 28 recruiting studies, sorted by proximity — each links to its official registry page
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Phase 2
Interventional 204 participants sought
Care Access-Lake Charles, LA — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 3
Interventional 600 participants sought
Clinical Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: MoonLake Immunotherapeutics AG
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 320 participants sought
Research Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 245 participants sought
Research Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AstraZeneca
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: 89bio, Inc.
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 120 participants sought
Accurate Clinical Research Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Hoffmann-La Roche
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Accurate Clinical Research — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: 89bio, Inc.
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Phase 3
Interventional 600 participants sought
Accurate Clinical Research, Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
Study of GS-0151 in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 1
Interventional 75 participants sought
Accurate Clinical Research, Inc — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Gilead Sciences
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Phase 3
Interventional 3,040 participants sought
Shondra L. Smith, MD - Dermatology and Advanced Aesthetics — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Bristol-Myers Squibb
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Primary Sjogren's Disease
Phase 3
Interventional 250 participants sought
Accurate Clinical Research, Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Vor Biopharma
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Obesity, Overweight
Phase 3
Interventional 1,980 participants sought
Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy
Phase 2
Interventional 240 participants sought
Central Recruiting Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Dogwood Therapeutics Inc.
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AstraZeneca
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 624 participants sought
GSK Investigational Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: GlaxoSmithKline
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Psoriatic Arthritis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Accurate Clinical Research, Inc — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
Obesity, Overweight
Phase 3
Interventional 586 participants sought
Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 1,196 participants sought
GSK Investigational Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: GlaxoSmithKline
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Sameek Roychowdhury
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Accurate Clinical Research (SMO/Network/Consortium) /ID# 272650 — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AbbVie
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1030 — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Immunovant Sciences GmbH
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Lupus Nephritis
Phase 4
Interventional 150 participants sought
Accurate Clinical Research, Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Aurinia Pharmaceuticals Inc.
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Obesity or Overweight, Type 2 Diabetes Mellitus
Phase 3
Interventional 1,600 participants sought
Elevate Clinical Research — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Hoffmann-La Roche
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50285 — Lake Charles, Louisiana (0.9 mi)
· Sponsor: UCB Biopharma SRL